<!DOCTYPE html>
    <html lang="en">
    
    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <script async src="https://www.googletagmanager.com/gtag/js?id=G-PQPWWZGD1B"></script>
        <script>
        window.dataLayer = window.dataLayer || [];
        function gtag(){dataLayer.push(arguments);}
        gtag('js', new Date());

        gtag('config', 'G-PQPWWZGD1B');
        </script>
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-7833742603914548"
     crossorigin="anonymous"></script>
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.0/dist/katex.min.css" integrity="sha384-Xi8rHCmBmhbuyyhbI88391ZKP2dmfnOl4rT9ZfRI7mLTdk1wblIUnrIq35nqwEvC" crossorigin="anonymous">
        <link rel="stylesheet" href="../assets/css/min/@ui.css">
        <link rel="shortcut icon" href="../assets/images/favicons/favicon.ico">
        <link rel="apple-touch-icon-precomposed" href="../assets/images/favicons/apple-touch-icon-152x152-precomposed.png">
        <link rel="apple-touch-icon" sizes="180x180" href="../assets/images/favicons/apple-touch-icon.png">
        <link rel="icon" type="image/png" sizes="32x32" href="../assets/images/favicons/favicon-32x32.png">
        <link rel="icon" type="image/png" sizes="16x16" href="../assets/images/favicons/favicon-16x16.png">
        <link rel="manifest" href="../assets/images/favicons/site.webmanifest">
        <link rel="mask-icon" href="../assets/images/favicons/safari-pinned-tab.svg" color="#10106d">
        <meta name="msapplication-TileColor" content="#10106d">
        <meta name="msapplication-config" content="/assets/images/favicons/browserconfig.xml">
        <meta name="theme-color" content="#10106d">
        <link rel="canonical" href="https://vlavar.com/engineeringdb/a-number-of-amateur-and-professional-sports-organizations-use-routine-screening-tests-to-determine-if-athletes-are-using-performance-enhancing-drugs-jennifer-smith-president-of-an-amateur-athletic-u" />
        <meta property="og:locale" content="en_US" />
        <meta property="og:type" content="article" />
        <meta property="og:site_name" content="Vlavar" />
        <meta property="article:publisher" content="admin@vlavar" />
       <title>A number of amateur and professional sports organizations use routine screening tests to determine if athletes are using performance-enhancing drugs. Jennifer Smith, president of an amateur athletic union, has asked you to determine the feasibility of screening athletes to determine if they are [solved] | Vlavar Engineering</title>
<meta property="og:title" content="A number of amateur and professional sports organizations use routine screening tests to determine if athletes are using performance-enhancing drugs. Jennifer Smith, president of an amateur athletic union, has asked you to determine the feasibility of screening athletes to determine if they are[solved!] | Vlavar Engineering" />
<meta name="description" content="The first step in the analysis is to identify the events in the sample space: D_{1} : The athlete is a user of performance-enhancing drugs."/>
<meta property="og:description" content="The first step in the analysis is to identify the events in the sample space: D_{1} : The athlete is a user of performance-enhancing drugs." />

<meta property="og:updated_time" content="2022-06-27T19:34:18+04:00" />
<meta name="twitter:description" content="The first step in the analysis is to identify the events in the sample space: D_{1} : The athlete is a user of performance-enhancing drugs." />
<meta name="twitter:title" content="A number of amateur and professional sports organizations use routine screening tests to determine if athletes are using performance-enhancing drugs. Jennifer Smith, president of an amateur athletic union, has asked you to determine the feasibility of screening athletes to determine if they are[solved!] | Vlavar Engineering" />

<meta property="article:published_time" content="2022-06-22T17:51:42+04:00" />
        <meta property="og:url" content="https://vlavar.com/engineeringdb/a-number-of-amateur-and-professional-sports-organizations-use-routine-screening-tests-to-determine-if-athletes-are-using-performance-enhancing-drugs-jennifer-smith-president-of-an-amateur-athletic-u" />
        <meta property="article:author" content="admin@vlavar" />
        <meta name="twitter:card" content="summary_large_image" />
        <meta name="twitter:site" content="admin@vlavar" />
        <meta name="twitter:creator" content="admin@vlavar" />
     
    </head>
    
    <body>
        <nav id="desktop" class="desktop">
            <div id="desktop-container" class="container">
                <h1 id="logo"><a href="../index.html">Vlavar</a></h1>
                <div id="desktop-menu" class="menu">
                    <a href="../index.html">Home</a>
                    <a id="search">Search</a>
                    <a href="../tour/1.html">Tour</a>
                    <a href="../contact-us.html">Contact Us</a>
                </div>
                <button id="burger-button" class="hamburger">
                    <span></span>
                    <span></span>
                    <span></span>
                </button>
    
            </div>
        </nav>
        <nav id="mobile-navbar" class="mobile-nav">
            <div class="one text-fade"><a class="nav-link" href="../index.html">Home</a></div>
            <div class="two text-fade"><a class="nav-link" id="search-mobile">Search</a></div>
            <div class="three text-fade"><a class="nav-link" href="../tour/1.html">Tour</a></div>
            <div class="four text-fade"><a class="nav-link" href="../contact-us.html">COntact Us</a></div>
        </nav>
    
        <div id="container" class="container-items tour">
            <div id="searchbox" class="searchbox">
                <div class="search">
                    <div class="icon"></div>
                    <form class="form">
                        <div class="input">
                        <input type="text" id="x" placeholder="Find solutions to engineering problems " autocomplete="off" >

                        </div>
                    </form>
                </div>
            </div>
            <div class="items question-block"> <span class="question">Guest Question. </span>
            <p class="blog">A number of amateur and professional sports organizations use routine screening tests<br /> to determine if athletes are using performance-enhancing drugs. Jennifer Smith, president<br /> of an amateur athletic union, has asked you to determine the feasibility of screening<br /> athletes to determine if they are using performance-enhancing drugs. Amateur<br /> athletes are increasingly denied participation or deprived of victories if they are found<br /> to be users.<br /> As part of the study, you propose the following scenario for analysis. Suppose that<br /> 10% of the athletes seeking participation in the athletic union have used performanceenhancing<br /> drugs. In addition, suppose that a test is available that correctly identifies an<br /> athleteâ€™s drug usage 90% of the time. If an athlete is a drug user, the probability is 0.90<br /> that the athlete is correctly identified by the test as a drug user. Similarly, if the athlete</p> <p class="blog">is not a drug user, the probability is 0.90 that the athlete is correctly identified as not<br /> using performance-enhancing drugs.<br /> We should note that there are potential ethical and possible legal questions concerning<br /> the use of these tests. Here, we are concerned about the feasibility of using such<br /> a test if one has decided that such a test is proper, given the legal and value systems.</p>      
    <!-- end -->
            </div>
    
            <div class="items blog-solution">
                <div class="admin"><span>Admin</span> <svg class="verified-badge" xmlns="http://www.w3.org/2000/svg"
                        version="1.1" viewBox="0,0,24,24">
                        <path
                            d="M22.5 12.5c0-1.58-.875-2.95-2.148-3.6.154-.435.238-.905.238-1.4 0-2.21-1.71-3.998-3.818-3.998-.47 0-.92.084-1.336.25C14.818 2.415 13.51 1.5 12 1.5s-2.816.917-3.437 2.25c-.415-.165-.866-.25-1.336-.25-2.11 0-3.818 1.79-3.818 4 0 .494.083.964.237 1.4-1.272.65-2.147 2.018-2.147 3.6 0 1.495.782 2.798 1.942 3.486-.02.17-.032.34-.032.514 0 2.21 1.708 4 3.818 4 .47 0 .92-.086 1.335-.25.62 1.334 1.926 2.25 3.437 2.25 1.512 0 2.818-.916 3.437-2.25.415.163.865.248 1.336.248 2.11 0 3.818-1.79 3.818-4 0-.174-.012-.344-.033-.513 1.158-.687 1.943-1.99 1.943-3.484zm-6.616-3.334l-4.334 6.5c-.145.217-.382.334-.625.334-.143 0-.288-.04-.416-.126l-.115-.094-2.415-2.415c-.293-.293-.293-.768 0-1.06s.768-.294 1.06 0l1.77 1.767 3.825-5.74c.23-.345.696-.436 1.04-.207.346.23.44.696.21 1.04z"
                            fill="#1da1f2" />
                    </svg> </div>
    
                <div class="solution">Solution</div>
    
            </div>
    
            <div class="items answer-block">
                <p class="blog">
The first step in the analysis is to identify the events in the sample space:<br /> <span class="tex-text">\(D_{1}\)</span> : The athlete is a user of performance-enhancing drugs.<br /> <span class="tex-text">\(D_{2}\)</span>: The athlete is not a user of performance-enhancing drugs.<br /> The proposed test indicates positive or negative results:<br /> <span class="tex-text">\(T_{1}\)</span>: Test says that the athlete is a user of performance-enhancing drugs.<br /> <span class="tex-text">\(T_{2}\)</span>: Test says that the athlete is not a user of performance-enhancing drugs.<br /> From the information provided, the following probabilities can be defined:</p>
 <p class="blog">
<span class="tex-text">\(P\left(D_{1} \right) =0.10\)</span> <span class="tex-text">\(P\left(D_{2} \right) =0.90\)</span></p>
 <p class="blog">
<span class="tex-text">\(P\left(T_{1}\setminus D_{1} \right) =0.90\)</span> <span class="tex-text">\(P\left(T_{2} \setminus D_{1} \right) =0.10\)</span></p>
 <p class="blog">
<span class="tex-text">\(P\left(T_{1}\setminus D_{2} \right) =0.10\)</span> <span class="tex-text">\(P\left(T_{2}\setminus D_{2} \right) =0.90\)</span></p>
 <p class="blog">
Using these probabilities, a two-way table, Table 3.11, containing the joint probabilities<br /> can be constructed:</p>
 <p class="blog">
<span class="tex-text">\(P\left(D_{1}\cap T_{1} \right) =P\left(T_{1} D_{1} \right) P\left(D_{1} \right) =0.90\times 0.10=0.09\)</span><br /> <span class="tex-text">\(P\left(D_{1}\cap T_{2} \right) =P\left(T_{2} D_{1} \right) P\left(D_{1} \right)=0.10\times 0.10=0.01\)</span><br /> <span class="tex-text">\(P\left(D_{2}\cap T_{1} \right) =P\left(T_{1} D_{2} \right) P\left(D_{2} \right)=0.10\times 0.90=0.09\)</span><br /> <span class="tex-text">\(P\left(D_{2}\cap T_{2} \right) =P\left(T_{2} D_{2} \right) P\left(D_{2} \right) =0.90\times 0.90=0.81\)</span></p>
 <p class="blog">
Table 3.11 Drug Test Subgroups</p>
 <div class="table-overflow"><table  width="1090"> <tbody> <tr> <td width="253"></td> <td width="402"> <span class="tex-text">\(T_{1} \)</span>(TEST SAYS DRUG USER)</td> <td width="363"><span class="tex-text">\(T_{2} \)</span> (TEST SAYS NOT A DRUG USER)</td> <td width="72">TOTAL</td> </tr> <tr> <td><span class="tex-text">\(D_{1} \)</span> (Drug User)</td> <td>0.09</td> <td>0.01</td> <td>0.1</td> </tr> <tr> <td><span class="tex-text">\(D_{2} \)</span>(Not a Drug User)</td> <td>0.09</td> <td>0.81</td> <td>0.9</td> </tr> <tr> <td>Total</td> <td>0.18</td> <td>0.82</td> <td>1</td> </tr> </tbody> </table></div> <p class="blog">
From Table 3.11 we can easily determine the conditional probability of a drug user,<br /> given that the test says drug user, by dividing the joint probability of <span class="tex-text">\(D_{1} \)</span> and <span class="tex-text">\(T_{1} \)</span> (0.09)<br /> by the marginal probability of <span class="tex-text">\(T_{1} \)</span> (0.18):</p>
 <span class="tex-text">\(P\left(D_{1} \setminus T_{1} \right) =\frac{P\left(D_{1}\cap T_{1} \right) }{P\left(T_{1} \right) } =\frac{0.09}{0.18} =0.50\)</span> <p class="blog">
Similarly, the probability of not a drug user, given that the test says not a drug user, can<br /> be obtained from the second column:</p>
 <span class="tex-text">\(P\left(D_{2} \setminus T_{2} \right) =\frac{P\left(D_{2}\cap T_{2} \right) }{P\left(T_{2} \right) } =\frac{0.81}{0.82} =0.988\)</span> <p class="blog">
From these results we see that, if the test says an athlete is not a drug user, the<br /> probability is very high that the test result is correct. However, if the test says that the<br /> athlete is a drug user, the probability is only 0.50 that the athlete is a drug user. This is<br /> a large increase over a probability of 0.10 for a randomly selected athlete. However, it is<br /> clear that the athletic association would not want to reject athletes merely on the results<br /> of this screening test. The potential for unethical actions and serious legal challenge</p>
 <p class="blog">
would be too great. The best strategy would be to use a second independent test to<br /> further screen the athlete identified as a drug user by the first test. We stress again that<br /> there may be serious ethical and medical concerns if athletes are rejected on the basis of<br /> only the first test!</p>
 
    
          <!-- end -->
            </div>
        </div>
    
    
        <footer class="footer-bg footer-slct">
            <div class="footer-top">
                <a href="../tos.html">terms</a>
                <a href="../privacy.html">privacy</a>
                <a href="../contact-us.html">contact us</a>
            </div>
            <div class="footer-bottom">
                &copy; 2022 Vlavar Inc. All Rights Reserved.
            </div>
        </footer>    
        <script src="https://cdn.jsdelivr.net/npm/katex@0.16.0/dist/katex.min.js" integrity="sha384-X/XCfMm41VSsqRNQgDerQczD69XqmjOOOwYQvr/uuC+j4OPoNhVgjdGFwhvN02Ja" crossorigin="anonymous"></script>
        <script src="https://cdn.jsdelivr.net/npm/katex@0.16.0/dist/contrib/auto-render.min.js" integrity="sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR" crossorigin="anonymous"></script>
        <script src="../assets/js/min/client-ui.js"></script>
    </body>
    
    </html>